Omari Bouknight

CardioNet LLC provides cardiac monitoring services. It operates its business through two segments: Patient Service and Product Business. The Patient Service segment focuses on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, through its core mobile cardiac outpatient telemetry, event and Holter services. The Product Business segment focuses on the development, manufacturing, testing and marketing of medical devices and related software to medical companies, clinics and hospitals. The company was founded by James M. Sweeney in 1999 and is headquartered in Conshohocken, PA.

A division of C. R. Bard Inc., Bard Electrophysiology is a global company focused on the development and delivery of a broad range of devices for the diagnosis and treatment of cardiac arrhythmias. Bard Electrophysiology offers a full product portfolio which includes advanced RF ablation and mapping catheters, diagnostic catheters, computer-based electrophysiology mapping and recording systems, temporary pacing electrodes and vascular/cardiac access devices. Through their rich history of commitment to innovative products, unparalleled support and a dedication to education worldwide, Bard Electrophysiology continues to be a leader in the field of EP.